# Treatment of Bevacizumab Followed by Steroid in RN

> **NCT04553510** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 86 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma
- Adverse Effect of Radiation Therapy
- Brain Injuries

## Interventions

- **DRUG:** Bevacizumab and steroid
- **DRUG:** Bevacizumab and placebo

## Key facts

- **NCT ID:** NCT04553510
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-06-30
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2020-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04553510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04553510, "Treatment of Bevacizumab Followed by Steroid in RN". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04553510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*